A Randomised Clinical Trial of a Digital Self-management Package for People With Interstitial Lung Disease
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Sydney
About this trial
The goal of this clinical trial is to compare REBUILD-SM (a purpose-built smartphone app and self-management package) with standard care in people with interstitial lung disease (ILD). The main question it aims to answer is:
• Does REBUILD-SM improve health-related quality of life, symptoms, anxiety, self-efficacy and physical activity for people with ILD?
Participants in the intervention group will work through the self-management package with support from a healthcare professional via phone or Zoom. They will also enter deidentified health data into the RE-BUILD smartphone app to track their progress over time. Participants in the control group will use a reduced functionality version of the smartphone app only.
Researchers will compare both groups to see if there is any difference in health-related quality of life, symptoms, anxiety, self-efficacy and level of physical activity.
Eligibility criteria
Qualifiers
Diagnosis of fibrotic ILD
In possession of a smartphone/tablet and an email address
Able to understand written and spoken English
Adequate digital literacy to complete requirements of trial
Disqualifiers
Not in possession of a smartphone/tablet
Insufficient digital literacy to complete requirements of trial
Unable to communicate in written/spoken English
Not on stable ILD treatment for 30 days prior to enrolment
Trial design
Treatments tested in this trial
- Pulmonary Fibrosis self-management package and smartphone application
Treatment groups
400 Participants
are divided into 2 treatment groupsSponsors and collaborators
University of Sydney
Lead sponsor
Monash University
Collaborator
Lung Foundation Australia
Collaborator
University of Tasmania
Collaborator
Source ClinicalTrials.gov